IceCure Medical (NASDAQ:ICCM) Trading 6% Higher

IceCure Medical Ltd (NASDAQ:ICCMGet Rating) traded up 6% during mid-day trading on Friday . The stock traded as high as $1.83 and last traded at $1.83. 1,075 shares traded hands during trading, a decline of 97% from the average session volume of 42,065 shares. The stock had previously closed at $1.73.

Analyst Upgrades and Downgrades

Separately, Alliance Global Partners cut their price objective on IceCure Medical from $9.50 to $5.75 and set a “buy” rating on the stock in a research note on Thursday, May 19th.

IceCure Medical Price Performance

The business has a 50 day simple moving average of $1.77 and a 200-day simple moving average of $2.15. The company has a debt-to-equity ratio of 0.03, a quick ratio of 4.93 and a current ratio of 5.40.

IceCure Medical (NASDAQ:ICCMGet Rating) last issued its quarterly earnings results on Wednesday, May 18th. The company reported ($0.12) earnings per share (EPS) for the quarter. The business had revenue of $0.75 million during the quarter. Equities research analysts forecast that IceCure Medical Ltd will post -0.27 earnings per share for the current year.

Institutional Investors Weigh In On IceCure Medical

A hedge fund recently bought a new stake in IceCure Medical stock. Credit Suisse AG bought a new stake in IceCure Medical Ltd (NASDAQ:ICCMGet Rating) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 55,996 shares of the company’s stock, valued at approximately $52,468,000.

About IceCure Medical

(Get Rating)

IceCure Medical Ltd, a medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body. It offers ProSense system, a cryoablation solution for the treatment of breast tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.

Read More

Receive News & Ratings for IceCure Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IceCure Medical and related companies with's FREE daily email newsletter.